UNI-EN 23:Current report 23 Notification
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 23 | / | 2016 | | ||||||
| Date of issue: | 2016-02-26 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Current report 23 Notification | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| In relation to the right of the shareholders of Medica AD under art. 157b from the LPOS to request from the majority shareholder of Medica AD Sopharma AD to buy out their shares with voting right, we hereby inform you that Sopharma AD will use the services of investment intermediary Elana Trading AD for this process. Sopharma AD hereby kindly asks all shareholders who would like to exercise this right to file their written request for buy out, with all details concerning the shareholder and the shares owned by him with Elana Trading www.elana.net. In that respect we advise all such shareholders that they can contact Elana Trading Ad by email at brokers@elana.net and by telephone at 02/81 000 25 and 02/81 00026. We hereby notify also that the right under art. 157b from the LPOS can be exercised before May 16 2016 and that the majority shareholder Sopharma AD is obligated to conclude the transaction within one month from receiving the written request. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 23 Notification ENG.doc Current report 23 Notification ENG.doc | Current report 23 Notification | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2016-02-26 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 5.0 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
